CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 147 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $88,064,000 | -0.2% | 3,200,000 | +23.1% | 14.40% | +18.7% |
| Q2 2023 | $88,218,000 | +74.0% | 2,600,000 | +84.5% | 12.13% | +85.3% |
| Q1 2023 | $50,712,047 | -29.1% | 1,409,451 | -12.2% | 6.55% | -40.4% |
| Q4 2022 | $71,552,232 | +59.1% | 1,605,390 | +0.3% | 10.98% | +15.8% |
| Q3 2022 | $44,980,000 | +36.3% | 1,600,127 | +16.1% | 9.48% | +12.5% |
| Q2 2022 | $33,002,000 | +28.7% | 1,378,659 | +83.1% | 8.43% | +1.3% |
| Q1 2022 | $25,648,000 | +192.8% | 753,034 | +232.1% | 8.32% | +77.7% |
| Q4 2021 | $8,761,000 | – | 226,726 | – | 4.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 1,605,390 | $71,552,232 | 10.98% |
| Octagon Capital Advisors LP | 761,398 | $33,935,509 | 5.28% |
| TSP Capital Management Group, LLC | 269,895 | $12,029,225 | 4.50% |
| Redmile Group, LLC | 1,977,451 | $88,134,991 | 3.60% |
| COMMODORE CAPITAL LP | 495,823 | $22,099 | 3.33% |
| Tri Locum Partners LP | 176,109 | $7,849,000 | 3.18% |
| ACUTA CAPITAL PARTNERS, LLC | 115,000 | $5,125,550 | 3.15% |
| Ikarian Capital, LLC | 267,476 | $11,921,406 | 2.88% |
| RTW INVESTMENTS, LP | 3,084,215 | $137,463,463 | 2.81% |
| Eversept Partners, LP | 558,774 | $24,904,557 | 2.18% |